RHÖN-KLINIKUM Aktiengesellschaft (XETRA:RHK) — Stock Price
RHÖN-KLINIKUM Aktiengesellschaft (XETRA:RHK) is currently trading at €14.80 EUR, down 1.33% today. Over the past 52 weeks, shares have ranged between €11.30 and €15.00. This page tracks RHÖN-KLINIKUM Aktiengesellschaft's live share price on the XETRA exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see RHK stock market capitalisation.
RHÖN-KLINIKUM Aktiengesellschaft (RHK) Stock Price Chart — Daily History & Trading Volume
The chart below tracks RHÖN-KLINIKUM Aktiengesellschaft's daily closing share price and trading volume on the XETRA exchange over the past year, giving a clear view of recent price momentum and liquidity.
RHÖN-KLINIKUM Aktiengesellschaft Income Statement — Revenue, Profit & Earnings by Year
RHÖN-KLINIKUM Aktiengesellschaft's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | €1.60 Billion | €1.73 Billion | €1.45 Billion | €1.40 Billion | €1.36 Billion |
| Cost of Revenue | €1.42 Billion | €1.53 Billion | €446.56 Million | €430.39 Million | €422.44 Million |
| Gross Profit | €171.82 Million | €202.88 Million | €999.52 Million | €182.63 Million | €937.72 Million |
| Research & Development | — | — | — | — | — |
| SG&A | €69.40 Million | €70.30 Million | €21.70 Million | €20.20 Million | €24.20 Million |
| Total Operating Expenses | €123.67 Million | €162.48 Million | €963.25 Million | €152.11 Million | €926.30 Million |
| Operating Income | €48.15 Million | €40.40 Million | €36.11 Million | €30.52 Million | €10.60 Million |
| EBITDA | €122.23 Million | €116.58 Million | €106.15 Million | €100.21 Million | €80.66 Million |
| EBIT | €59.60 Million | €50.98 Million | €37.62 Million | €30.47 Million | €11.24 Million |
| Interest Expense | €3.40 Million | €3.70 Million | €4.10 Million | €3.20 Million | €7.39 Million |
| Income Before Tax | €56.20 Million | €47.73 Million | €33.63 Million | €27.36 Million | €3.93 Million |
| Income Tax Expense | €11.00 Million | €7.56 Million | €6.69 Million | €-2.87 Million | €1.47 Million |
| Net Income | €43.35 Million | €38.71 Million | €25.14 Million | €28.30 Million | €1.45 Million |
RHÖN-KLINIKUM Aktiengesellschaft Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes RHÖN-KLINIKUM Aktiengesellschaft's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | €1.86 Billion | €1.77 Billion | €1.70 Billion | €1.67 Billion | €1.63 Billion |
| Total Current Assets | €904.11 Million | €789.21 Million | €688.61 Million | €611.08 Million | €566.43 Million |
| Cash & Equivalents | €29.76 Million | €25.04 Million | €34.00K | €316.00K | €7.46 Million |
| Short-term Investments | €129.60 Million | €136.80 Million | €219.00 Million | €165.80 Million | €166.40 Million |
| Net Receivables | €415.10 Million | €394.68 Million | €351.74 Million | €279.07 Million | €194.60 Million |
| Inventory | €37.46 Million | €34.21 Million | €33.32 Million | €33.12 Million | €35.24 Million |
| Property, Plant & Equipment | €764.44 Million | €792.11 Million | €822.50 Million | €852.61 Million | €865.55 Million |
| Goodwill | €165.40 Million | €165.40 Million | €165.50 Million | €165.20 Million | €164.80 Million |
| Total Liabilities | €530.51 Million | €490.30 Million | €453.51 Million | €440.82 Million | €439.45 Million |
| Total Current Liabilities | €404.85 Million | €335.47 Million | €291.08 Million | €273.31 Million | €273.38 Million |
| Long-term Debt | €110.90 Million | €141.80 Million | €141.68 Million | €148.56 Million | €148.46 Million |
| Net Debt | €-130.26 Million | €-56.20 Million | €80.87 Million | €33.45 Million | €69.65 Million |
| Total Stockholder Equity | €1.30 Billion | €1.25 Billion | €1.22 Billion | €1.20 Billion | €1.17 Billion |
| Retained Earnings | €554.43 Million | €510.54 Million | €482.30 Million | €456.82 Million | €423.83 Million |
RHÖN-KLINIKUM Aktiengesellschaft Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how RHÖN-KLINIKUM Aktiengesellschaft generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | €127.60 Million | €109.00 Million | €60.30 Million | €97.50 Million | €113.30 Million |
| Capital Expenditures | €70.40 Million | €62.80 Million | €58.20 Million | €77.80 Million | €97.00 Million |
| Free Cash Flow | €57.20 Million | €46.20 Million | €-16.90 Million | €19.70 Million | €16.30 Million |
| Investing Cash Flow | €-50.40 Million | €40.90 Million | €-105.20 Million | €-58.30 Million | €-135.20 Million |
| Financing Cash Flow | €-3.30 Million | €-21.20 Million | €-4.10 Million | €-3.90 Million | €-15.10 Million |
| Dividends Paid | €0.00 | €10.00 Million | €0.00 | — | €0.00 |
| Stock-Based Compensation | — | — | €300.00K | — | €100.00K |
| Depreciation | €62.60 Million | €65.60 Million | €69.60 Million | €70.20 Million | €69.80 Million |
| Change in Cash | €73.90 Million | €128.70 Million | €-49.00 Million | €35.30 Million | €-37.00 Million |
RHÖN-KLINIKUM Aktiengesellschaft Earnings History — EPS Actual vs. Analyst Estimates
Track RHÖN-KLINIKUM Aktiengesellschaft's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| May 06, 2026 | — | — | — |
| Mar 26, 2026 | — | — | — |
| Nov 06, 2025 | 0.15 | — | — |
| Aug 07, 2025 | 0.10 | — | — |
| May 08, 2025 | 0.11 | — | — |
| Mar 26, 2025 | 0.21 | — | — |
| Nov 07, 2024 | 0.14 | — | — |
| Aug 08, 2024 | 0.13 | — | — |